GM Insects and Moral Blackmail
By Jack Stilgoe and Sarah Hartley,
The Guardian [UK]
| 12. 17. 2015
Untitled Document
In October this year, we were both called as witnesses to the House of Lords Science and Technology Select Committee. The committee was looking at the potential of genetically modified insects and asking, among other questions, “Is there a role for responsible innovation approaches?” From their answer, it would appear that they think not. In choosing to swallow the promise of this technology without questioning its downsides, their report represents an unsophisticated form of moral blackmail.
The Lords have been persuaded that GM insects have the ability to save countless lives. They argue that we have a ‘moral duty’ to support the technology and clear out any regulation that might slow its development, as Tim Radford reports this morning. The report is framed in terms of supporting ‘UK plc’ (Oxitec, the world’s leading GM insect company, is a spin-off from Oxford University). They are motivated by the ‘presence of a pioneering company based in the UK, and the world class research being conducted in our universities and institutes’. Their version of the public interest is thin and undemocratic...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...